Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole has been characterized as a gastric proton-pump inhibitor.
Related products
-15%
Kumudini Pharma Ltd.
-13%
Flucloxacillin Sodium
-26%
Cefixime
-13%
Esomeprazole
-45%
Omeprazole
-24%
NIPRO JMI Pharmaceuticals Ltd.
-20%
Elemental Calcium + Vitamin D3 500 mg+200 IU
-35%
Esomeprazole